← 모든 태그

#KRX

26개의 글

Anguk Pharmaceutical (KRX: 001540) Stock Outlook 2026: A Cough-Syrup Cash Cow With a Family Governance Overhang

Anguk Pharmaceutical (KRX: 001540) Stock Outlook 2026: A Cough-Syrup Cash Cow With a Family Governance Overhang

Anguk Pharmaceutical (001540) stock outlook 2026 for foreign investors. A deep dive into its Sinectura respiratory-drug cash cow, incrementally modified drug and health-supplement expansion, family ownership governance risk, peer comparison against Korean small-cap pharma names, and how Korea's domestic securities transaction tax, dividend withholding tax, and major-shareholder capital gains rule actually apply to this KOSPI-listed stock.

Anguk Pharmaceutical 001540 Sinectura
GS Engineering & Construction (006360) Stock Outlook 2026: Housing Cycle, Overseas Orders, and the Xi Brand

GS Engineering & Construction (006360) Stock Outlook 2026: Housing Cycle, Overseas Orders, and the Xi Brand

A 2026 stock outlook for GS Engineering & Construction (KRX: 006360), covering Korea's housing and pre-sale cycle, overseas plant and infrastructure orders, the Xi apartment brand, raw-material and labor cost pressure, post-Geomdan trust recovery, water and modular new businesses, dividends, and a low-PBR value-up thesis, with a global-investor framing on KRW FX and cyclicality.

GS Engineering Construction 006360 Korean construction
SK IE Technology (361610) Stock Outlook 2026: A Top-Tier Separator Maker Crossing the EV Chasm

SK IE Technology (361610) Stock Outlook 2026: A Top-Tier Separator Maker Crossing the EV Chasm

SK IE Technology (SKIET, KRX 361610) stock outlook for 2026, covering its global wet-separator leadership, weak utilization and margins from the EV demand chasm, low-cost Chinese separator competition, Poland expansion and cell-maker customer mix, capex and balance-sheet strain, the FCW flexible cover window business, SK Innovation group governance, the turnaround question, and what US-based investors should weigh on currency and taxes.

SK IE Technology SKIET 361610